Startups

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Summary

Seedtable Score
  • 12
Locations
Company Size
  • 51 to 100 employees
Last Stage Round

Total funding Amount

$260M

Fundraising History

Investors